MBRX · CIK 0001659617 · operating
Moleculin Biotech, Inc. (MBRX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $8 million, Moleculin Biotech, Inc. is a micro-cap company. The stock currently trades at $2.40, up 0.42% today, with a 52-week range of $2.25–$35.13.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | $-6.32 | +58.1% | |
| 2023 | — | $-15.07 | -1392.1% | |
| 2022 | — | $-1.01 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-21 | 0001437749-25-008751 | SEC ↗ |
| 2023-12-31 | 2024-03-22 | 0001437749-24-009044 | SEC ↗ |
| 2022-12-31 | 2023-03-22 | 0001437749-23-007537 | SEC ↗ |
| 2021-12-31 | 2022-03-24 | 0001437749-22-007103 | SEC ↗ |
| 2020-12-31 | 2021-03-24 | 0001437749-21-006940 | SEC ↗ |
| 2019-12-31 | 2020-03-19 | 0001659617-20-000066 | SEC ↗ |
| 2018-12-31 | 2019-02-21 | 0001659617-19-000018 | SEC ↗ |
| 2017-12-31 | 2018-03-28 | 0001659617-18-000027 | SEC ↗ |
| 2016-12-31 | 2017-04-03 | 0001144204-17-018352 | SEC ↗ |